Habit Logs
Sorry, You Have Been Blocked
Ottoline Dunmore · August 16, 2026
Discover how noninvasive imaging technologies like OCT and RCM can replace biopsies for diagnosing basal cell carcinoma, according to a recent review.
01
02
03
04
05
Direct-to-consumer drugs are transforming patient access to GLP-1 therapies, but hidden costs and coordination hurdles raise policy concerns for regulators.
Discover how noninvasive imaging technologies like OCT and RCM can replace biopsies for diagnosing basal cell carcinoma, according…
Learn why user access was blocked after a pharmacy policy breach and how strategic leadership can prevent future…
Discover why web access blocks are reported across the internet and how these disruptions impact global digital connectivity…
Direct-to-consumer drugs are transforming patient access to GLP-1 therapies, but hidden costs and coordination hurdles raise policy concerns…
Pharmacy benefit managers face new transparency rules under the 2026 federal law, reshaping drug negotiations and access for…
Early childhood may hold critical clues to reducing ADHD risk. Researchers track developmental risks from pregnancy through toddlerhood.
The 2026 cholesterol guideline expands therapy eligibility to over half of U.S. adults, highlighting new risk thresholds and…
Sleep deprivation can lead to decreased cognitive function and impaired motor skills, affecting individuals who work in high-pressure…
Narcolepsy treatment breakthrough as FDA approves Takeda's oral drug Orzeyful, offering the first therapy to target all type…
Sparsentan shows mixed results in FSGS Phase 3 trial compared to irbesartan, revealing key benefits and trial design…
